Post-kala-azar Dermal Leishmaniasis with Mucosal Involvement: An Unusual Case Presentation including Successful Treatment with Miltefosine

被引:0
|
作者
Salam, Md A. [1 ]
Siddiqui, Muhammad A. [1 ]
Nabi, Shah G. [2 ]
Bhaskar, Khondaker R. H. [3 ]
Mondal, Dinesh [3 ]
机构
[1] Rajshahi Med Coll, Rajshahi 6000, Bangladesh
[2] Directorate Gen Hlth Serv, Dhaka, Bangladesh
[3] Icddr B, Dhaka 1212, Bangladesh
关键词
Miltefosine; treatment; Mucosal involvement; Post-kala-azar dermal leishmaniasis; Bangladesh; DIAGNOSIS;
D O I
暂无
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Post-kala-azar dermal leishmaniasis (PKDL) is a dermatologic manifestation that usually occurs after visceral leishmaniasis (VL) caused by Leishmania donovani. It is characterized by hypopigmented patches, a macular or maculopapular rash and nodular skin lesions on the body surface. Involvement of the mucosae is very rare and unusual in PKDL. We report a case of PKDL that presented with polymorphic skin lesions, along with involvement of peri-oral mucosa and tongue from an endemic area for kala-azar in Bangladesh. In the absence of a definite past history of kala-azar, a clinical suspicion for PKDL was confirmed by positive rapid serological tests against two recombinant (rK39 and rK28) leishmanial antigens, demonstration of Leishmania donovani (LD) body in the slit skin smear, and isolation of promastigotes by culture from a nodular lesion. The patient was treated with oral Miltefosine for three consecutive months and showed significant clinical improvement as demonstrated by a negative slit skin smear at two months after initiation of therapy. We report this case as an unusual presentation of mucosal involvement in PKDL and subsequent treatment success with Miltefosine.
引用
收藏
页码:294 / 297
页数:4
相关论文
共 50 条
  • [41] Quantifying the Infectiousness of Post-Kala-Azar Dermal Leishmaniasis Toward Sand Flies
    Mondal, Dinesh
    Bern, Caryn
    Ghosh, Debashis
    Rashid, Masud
    Molina, Ricardo
    Chowdhury, Rajashree
    Nath, Rupen
    Ghosh, Prakash
    Chapman, Lloyd A. C.
    Alim, Abdul
    Bilbe, Graeme
    Alvar, Jorge
    CLINICAL INFECTIOUS DISEASES, 2019, 69 (02) : 251 - 258
  • [42] Relationship of Serum Antileishmanial Antibody With Development of Visceral Leishmaniasis, Post-kala-azar Dermal Leishmaniasis and Visceral Leishmaniasis Relapse
    Mondal, Dinesh
    Ghosh, Prakash
    Chowdhury, Rajashree
    Halleux, Christine
    Ruiz-Postigo, Jose A.
    Alim, Abdul
    Hossain, Faria
    Khan, Md Anik Ashfaq
    Nath, Rupen
    Duthie, Malcolm S.
    Kroeger, Axel
    Matlashewski, Greg
    Argaw, Daniel
    Olliaro, Piero
    FRONTIERS IN MICROBIOLOGY, 2019, 10
  • [43] Post-Kala-azar Dermal Leishmaniasis in Nepal: A Retrospective Cohort Study (2000-2010)
    Uranw, Surendra
    Ostyn, Bart
    Rijal, Arpana
    Devkota, Saru
    Khanal, Basudha
    Menten, Joris
    Boelaert, Marleen
    Rijal, Suman
    PLOS NEGLECTED TROPICAL DISEASES, 2011, 5 (12):
  • [44] Safety and Effectiveness of Short-Course AmBisome in the Treatment of Post-Kala-Azar Dermal Leishmaniasis: A Prospective Cohort Study in Bangladesh
    den Boer, Margriet
    Das, Asish Kumar
    Akhter, Fatima
    Burza, Sakib
    Ramesh, V.
    Ahmed, Be-Nazir
    Zijlstra, Eduard E.
    Ritmeijer, Koert
    CLINICAL INFECTIOUS DISEASES, 2018, 67 (05) : 667 - 675
  • [45] Assessing the Efficacy and Safety of Liposomal Amphotericin B and Miltefosine in Combination for Treatment of Post Kala-Azar Dermal Leishmaniasis
    Ramesh, V
    Dixit, Keerti Kaumudee
    Sharma, Neha
    Singh, Ruchi
    Salotra, Poonam
    JOURNAL OF INFECTIOUS DISEASES, 2020, 221 (04) : 608 - 617
  • [46] Therapeutic Modalities in Post Kala-azar Dermal Leishmaniasis: A Systematic Review of the Effectiveness and Safety of the Treatment Options
    Datta, Adrija
    Podder, Indrashis
    Das, Anupam
    Sil, Amrita
    Das, Nilay Kanti
    INDIAN JOURNAL OF DERMATOLOGY, 2021, 66 (01) : 34 - 43
  • [47] The importance of T cell-derived cytokines in post-kala-azar dermal leishmaniasis
    Jafarzadeh, Abdollah
    Jafarzadeh, Sara
    Sharifi, Iraj
    Aminizadeh, Najmeh
    Nozari, Parvin
    Nemati, Maryam
    CYTOKINE, 2021, 147
  • [48] Decline in Clinical Efficacy of Oral Miltefosine in Treatment of Post Kala-azar Dermal Leishmaniasis (PKDL) in India
    Ramesh, V.
    Singh, Ruchi
    Avishek, Kumar
    Verma, Aditya
    Deep, Deepak Kumar
    Verma, Sandeep
    Salotra, Poonam
    PLOS NEGLECTED TROPICAL DISEASES, 2015, 9 (10):
  • [49] Post-kala-azar dermal leishmaniasis in the Indian subcontinent: A threat to the South-East Asia Region Kala-azar Elimination Programme.
    Zijlstra, Eduard E.
    Alves, Fabiana
    Rijal, Suman
    Arana, Byron
    Alvar, Jorge
    PLOS NEGLECTED TROPICAL DISEASES, 2017, 11 (11):
  • [50] Report of the Fifth Post-Kala-Azar Dermal Leishmaniasis Consortium Meeting, Colombo, Sri Lanka, 14-16 May 2018
    Zijlstra, Eduard E.
    Kumar, Amresh
    Sharma, Abhijit
    Rijal, Suman
    Mondal, Dinesh
    Routray, Satyabrata
    PARASITES & VECTORS, 2020, 13 (01)